Joanne Wuensch
Stock Analyst at Citigroup
(3.93)
# 609
Out of 5,241 analysts
478
Total ratings
56.41%
Success rate
8.01%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Neutral | $374 → $350 | $322.32 | +8.59% | 28 | May 7, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $9 → $11 | $14.10 | -21.99% | 18 | May 6, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $155 → $157 | $114.00 | +37.72% | 24 | May 4, 2026 | |
| DXCM DexCom | Maintains: Buy | $84 → $79 | $61.63 | +28.18% | 19 | May 4, 2026 | |
| ITGR Integer Holdings | Maintains: Neutral | $92 → $89 | $88.16 | +0.95% | 11 | May 1, 2026 | |
| GKOS Glaukos | Maintains: Buy | $135 → $140 | $144.01 | -2.78% | 24 | Apr 30, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $80 → $65 | $60.76 | +6.98% | 10 | Apr 30, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $98 → $95 | $83.70 | +13.50% | 25 | Apr 29, 2026 | |
| MDT Medtronic | Maintains: Buy | $117 → $110 | $76.15 | +44.45% | 23 | Apr 7, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $94 → $87 | $52.68 | +65.15% | 38 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $385 | $306.76 | +25.51% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $338 → $230 | $147.46 | +55.97% | 19 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $10.80 | +112.96% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $274 | $226.71 | +20.86% | 18 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $56.29 | +24.36% | 12 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $81 → $74 | $65.76 | +12.53% | 9 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $17.30 | +9.83% | 23 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $136 | $84.47 | +61.00% | 24 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $590 | $421.12 | +40.10% | 20 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.1 → $6.5 | $4.98 | +30.52% | 15 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $88 → $87 | $59.61 | +45.95% | 23 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $16.09 | +30.52% | 7 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $81.38 | +24.11% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $12.82 | +71.61% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.27 | +226.77% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $143.47 | +74.25% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $63.64 | +8.42% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $201.88 | -37.09% | 6 | Dec 10, 2018 |
Penumbra
May 7, 2026
Maintains: Neutral
Price Target: $374 → $350
Current: $322.32
Upside: +8.59%
Integra LifeSciences Holdings
May 6, 2026
Maintains: Sell
Price Target: $9 → $11
Current: $14.10
Upside: -21.99%
iRhythm Holdings
May 4, 2026
Maintains: Buy
Price Target: $155 → $157
Current: $114.00
Upside: +37.72%
DexCom
May 4, 2026
Maintains: Buy
Price Target: $84 → $79
Current: $61.63
Upside: +28.18%
Integer Holdings
May 1, 2026
Maintains: Neutral
Price Target: $92 → $89
Current: $88.16
Upside: +0.95%
Glaukos
Apr 30, 2026
Maintains: Buy
Price Target: $135 → $140
Current: $144.01
Upside: -2.78%
GE HealthCare Technologies
Apr 30, 2026
Maintains: Neutral
Price Target: $80 → $65
Current: $60.76
Upside: +6.98%
Zimmer Biomet Holdings
Apr 29, 2026
Maintains: Neutral
Price Target: $98 → $95
Current: $83.70
Upside: +13.50%
Medtronic
Apr 7, 2026
Maintains: Buy
Price Target: $117 → $110
Current: $76.15
Upside: +44.45%
Boston Scientific
Apr 7, 2026
Maintains: Buy
Price Target: $94 → $87
Current: $52.68
Upside: +65.15%
Apr 7, 2026
Maintains: Buy
Price Target: $420 → $385
Current: $306.76
Upside: +25.51%
Apr 7, 2026
Downgrades: Neutral
Price Target: $338 → $230
Current: $147.46
Upside: +55.97%
Mar 31, 2026
Initiates: Buy
Price Target: $23
Current: $10.80
Upside: +112.96%
Mar 11, 2026
Maintains: Buy
Price Target: $250 → $274
Current: $226.71
Upside: +20.86%
Mar 11, 2026
Maintains: Neutral
Price Target: $75 → $70
Current: $56.29
Upside: +24.36%
Mar 11, 2026
Maintains: Neutral
Price Target: $81 → $74
Current: $65.76
Upside: +12.53%
Mar 11, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $17.30
Upside: +9.83%
Mar 11, 2026
Maintains: Buy
Price Target: $140 → $136
Current: $84.47
Upside: +61.00%
Mar 11, 2026
Upgrades: Buy
Price Target: $590
Current: $421.12
Upside: +40.10%
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $4.98
Upside: +30.52%
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $59.61
Upside: +45.95%
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $16.09
Upside: +30.52%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $81.38
Upside: +24.11%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $12.82
Upside: +71.61%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.27
Upside: +226.77%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $143.47
Upside: +74.25%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $63.64
Upside: +8.42%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $201.88
Upside: -37.09%